Catalent Appoints Two Senior Executives to Support Global Development and Clinical Services Business Growth

Catalent Pharma Solutions has announced two appointments to the management structure of its development and clinical services division, to further support its global customer needs. The move sees the creation of two new senior leadership roles to support drug development and clinical trial growth in the US, Europe and Asia.
 

Mr Paul Hegwood, currently VP Operations for the clinical supply services offerings will assume the new role of VP Operations for the development and clinical services division for the Americas and Asia-Pacific regions. Mr Stuart Cryer, who is currently VP Operations for the development and analytical solutions offerings, will become the new VP Operations for the development and clinical services division for Europe and the rest of world.

“These appointments are part of our strategic investment and growth strategy across our global network, especially for our fast growing clinical supply services network, which comprises eight GMP facilities and over 50 depots across all continents,” commented Scott Houlton, President and CEO, development and clinical services. “The move provides further regional customer focus, plus greater local regulatory expertise, and will facilitate faster execution to support our clients’ needs wherever they are in the world.”

Paul Hegwood was named Vice President of global operational excellence for Catalent in April 2011, following an extensive career leading multi-national teams in operations, business development and product engineering. He had previously held the position of VP of global operations for Stanadyne Corp. and has held various leadership positions at General Motors and its automotive electronics and technology company, Delphi. He holds an MBA from the University of Michigan and a BME from Kettering University. Mr Hegwood is a trained specialist in lean manufacturing and is a certified Six Sigma Green Belt.
 

Mr Cryer has a Bachelor of Pharmacy honors degree from Bath University and more than 25 years’ experience in the pharmaceutical industry. He has worked for a broad range of pharmaceutical organisations including Pfizer, Abbott, GSK and Aptuit. He has held roles in formulation and development, technical support and operational management.